Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan-Feb;27(1):86-87.
doi: 10.1016/j.pulmoe.2020.10.004. Epub 2020 Oct 21.

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?

C S Kow  1 , S S Hasan  2
Affiliations
Comment

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?

C S Kow et al. Pulmonology. 2021 Jan-Feb.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Cortegiani A., Ippolito M., Greco M., Granone V., Protti A., Gregoretti C. Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review. Pulmonology. 2020 doi: 10.1016/j.pulmoe.2020.07.003. [published online ahead of print, 2020 Jul 20] S2531-0437(20)30153-30157. Online ahead of print. - DOI - PMC - PubMed
    1. Biran N., Ip A., Ahn J., Go R.C., Wang S., Mathura S. Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol. 2020;2:e603–12. doi: 10.1016/S2665-9913(20)30277-0. - DOI - PMC - PubMed
    1. Rosas I., Bräu N., Waters M., Go R.C., Hunter B.D., Bhagani S. Tocilizumab in hospitalized patients with COVID-19 pneumonia. Preprint. medRxiv. 2020 2020.08.27.20183442. - PMC - PubMed
    1. Roche. Roche’s phase III EMPACTA study showed Actemra/RoActemra reduced the likelihood of needing mechanical ventilation in hospitalised patients with COVID-19 associated pneumonia. [Accessed 24 September 2020]. https://www.roche.com/media/releases/med-cor-2020-09-18.htm.
    1. Blot M., Bourredjem A., Binquet C., Piroth L., LYMPHONIE Study Group Is interleukin 6 the right target in COVID-19 severe pneumonia? Am J Respir Crit Care Med. 2020 doi: 10.1164/rccm.202007-202924LE. [published online ahead of print, 2020 Sep 21] - DOI - PMC - PubMed